Group 1 - The company issued 8.6 million convertible bonds on April 14, 2023, with an initial conversion price of 27.64 CNY per share, which has been adjusted to 26.12 CNY per share as of October 20, 2023 [1] - The conversion price will be adjusted based on specific corporate actions such as stock dividends, capital increases, and cash dividends, following a defined formula [2][3] - The company approved a profit distribution plan for the fiscal year 2024, which includes a cash dividend of 0.7619998 CNY per share, leading to an adjustment of the conversion price to 25.36 CNY per share effective from May 27, 2025 [3][4] Group 2 - The adjusted conversion price reflects the company's commitment to protecting the interests of convertible bondholders during changes in equity structure [3] - The company will announce any adjustments to the conversion price in accordance with relevant laws and regulations, ensuring transparency and fairness [3] - The profit distribution plan is based on a total of 525,619,398 shares, indicating the scale of the company's equity distribution [4]
百洋医药: 关于调整百洋转债转股价格的公告